In this study, we observe the same variation of GLI1 levels (Figure 4A and 4B) and show that this variability could be correlated with the aggressiveness of the BCC tumor, where lower GLI1 expression levels correspond to more aggressive BCC subtypes (Figure 6B). The gene discussed is GLI1; the disease is skin basal cell carcinoma.